English
简体中文
Total: £ 56.28
Published Date: 2025-09-05 | Pages: 72 | Tables: 71 | Medical Care
The global market for Angioedema Treatment was valued at US$ 2680 million in the year 2024 and is projected to reach a revised size of US$ 5015 million by 2031, growing at a CAGR of 9.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Angioedema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angioedema Treatment.
The Angioedema Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Angioedema Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angioedema Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
F.Hoffmann-La Roche AG
Bausch Health
GlaxoSmithKline
AstraZeneca
Sanofi SA
Merck＆Co
Segment by Type
Antihistamines
Corticosteroids
Others
Segment by Application
Hospitals
Clinics
Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angioedema Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angioedema Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Angioedema Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angioedema Treatment Market Perspective (2020-2031)
2.2 Global Angioedema Treatment Growth Trends by Region
2.2.1 Global Angioedema Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Angioedema Treatment Historic Market Size by Region (2020-2025)
2.2.3 Angioedema Treatment Forecasted Market Size by Region (2026-2031)
2.3 Angioedema Treatment Market Dynamics
2.3.1 Angioedema Treatment Industry Trends
2.3.2 Angioedema Treatment Market Drivers
2.3.3 Angioedema Treatment Market Challenges
2.3.4 Angioedema Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angioedema Treatment Players by Revenue
3.1.1 Global Top Angioedema Treatment Players by Revenue (2020-2025)
3.1.2 Global Angioedema Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Angioedema Treatment Revenue
3.4 Global Angioedema Treatment Market Concentration Ratio
3.4.1 Global Angioedema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angioedema Treatment Revenue in 2024
3.5 Global Key Players of Angioedema Treatment Head office and Area Served
3.6 Global Key Players of Angioedema Treatment, Product and Application
3.7 Global Key Players of Angioedema Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Angioedema Treatment Breakdown Data by Type
4.1 Global Angioedema Treatment Historic Market Size by Type (2020-2025)
4.2 Global Angioedema Treatment Forecasted Market Size by Type (2026-2031)
5 Angioedema Treatment Breakdown Data by Application
5.1 Global Angioedema Treatment Historic Market Size by Application (2020-2025)
5.2 Global Angioedema Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Angioedema Treatment Market Size (2020-2031)
6.2 North America Angioedema Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Angioedema Treatment Market Size by Country (2020-2025)
6.4 North America Angioedema Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angioedema Treatment Market Size (2020-2031)
7.2 Europe Angioedema Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Angioedema Treatment Market Size by Country (2020-2025)
7.4 Europe Angioedema Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angioedema Treatment Market Size (2020-2031)
8.2 Asia-Pacific Angioedema Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Angioedema Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Angioedema Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angioedema Treatment Market Size (2020-2031)
9.2 Latin America Angioedema Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Angioedema Treatment Market Size by Country (2020-2025)
9.4 Latin America Angioedema Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angioedema Treatment Market Size (2020-2031)
10.2 Middle East & Africa Angioedema Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Angioedema Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Angioedema Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Angioedema Treatment Introduction
11.1.4 AstraZeneca Revenue in Angioedema Treatment Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 F.Hoffmann-La Roche AG
11.2.1 F.Hoffmann-La Roche AG Company Details
11.2.2 F.Hoffmann-La Roche AG Business Overview
11.2.3 F.Hoffmann-La Roche AG Angioedema Treatment Introduction
11.2.4 F.Hoffmann-La Roche AG Revenue in Angioedema Treatment Business (2020-2025)
11.2.5 F.Hoffmann-La Roche AG Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Angioedema Treatment Introduction
11.3.4 Bausch Health Revenue in Angioedema Treatment Business (2020-2025)
11.3.5 Bausch Health Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Angioedema Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Angioedema Treatment Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Angioedema Treatment Introduction
11.5.4 AstraZeneca Revenue in Angioedema Treatment Business (2020-2025)
11.5.5 AstraZeneca Recent Development
11.6 Sanofi SA
11.6.1 Sanofi SA Company Details
11.6.2 Sanofi SA Business Overview
11.6.3 Sanofi SA Angioedema Treatment Introduction
11.6.4 Sanofi SA Revenue in Angioedema Treatment Business (2020-2025)
11.6.5 Sanofi SA Recent Development
11.7 Merck＆Co
11.7.1 Merck＆Co Company Details
11.7.2 Merck＆Co Business Overview
11.7.3 Merck＆Co Angioedema Treatment Introduction
11.7.4 Merck＆Co Revenue in Angioedema Treatment Business (2020-2025)
11.7.5 Merck＆Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Angioedema Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antihistamines
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Others
Table 5. Global Angioedema Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Angioedema Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Angioedema Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Angioedema Treatment Market Share by Region (2020-2025)
Table 9. Global Angioedema Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Angioedema Treatment Market Share by Region (2026-2031)
Table 11. Angioedema Treatment Market Trends
Table 12. Angioedema Treatment Market Drivers
Table 13. Angioedema Treatment Market Challenges
Table 14. Angioedema Treatment Market Restraints
Table 15. Global Angioedema Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Angioedema Treatment Market Share by Players (2020-2025)
Table 17. Global Top Angioedema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angioedema Treatment as of 2024)
Table 18. Ranking of Global Top Angioedema Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Angioedema Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Angioedema Treatment, Headquarters and Area Served
Table 21. Global Key Players of Angioedema Treatment, Product and Application
Table 22. Global Key Players of Angioedema Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Angioedema Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Angioedema Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Angioedema Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Angioedema Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Angioedema Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Angioedema Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Angioedema Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Angioedema Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Angioedema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Angioedema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Angioedema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Angioedema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Angioedema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Angioedema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Angioedema Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Angioedema Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Angioedema Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Angioedema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Angioedema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Angioedema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Angioedema Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Angioedema Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Angioedema Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. AstraZeneca Company Details
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Angioedema Treatment Product
Table 50. AstraZeneca Revenue in Angioedema Treatment Business (2020-2025) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. F.Hoffmann-La Roche AG Company Details
Table 53. F.Hoffmann-La Roche AG Business Overview
Table 54. F.Hoffmann-La Roche AG Angioedema Treatment Product
Table 55. F.Hoffmann-La Roche AG Revenue in Angioedema Treatment Business (2020-2025) & (US$ Million)
Table 56. F.Hoffmann-La Roche AG Recent Development
Table 57. Bausch Health Company Details
Table 58. Bausch Health Business Overview
Table 59. Bausch Health Angioedema Treatment Product
Table 60. Bausch Health Revenue in Angioedema Treatment Business (2020-2025) & (US$ Million)
Table 61. Bausch Health Recent Development
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Angioedema Treatment Product
Table 65. GlaxoSmithKline Revenue in Angioedema Treatment Business (2020-2025) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Angioedema Treatment Product
Table 70. AstraZeneca Revenue in Angioedema Treatment Business (2020-2025) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Sanofi SA Company Details
Table 73. Sanofi SA Business Overview
Table 74. Sanofi SA Angioedema Treatment Product
Table 75. Sanofi SA Revenue in Angioedema Treatment Business (2020-2025) & (US$ Million)
Table 76. Sanofi SA Recent Development
Table 77. Merck＆Co Company Details
Table 78. Merck＆Co Business Overview
Table 79. Merck＆Co Angioedema Treatment Product
Table 80. Merck＆Co Revenue in Angioedema Treatment Business (2020-2025) & (US$ Million)
Table 81. Merck＆Co Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
Table 85. Authors List of This Report
List of Figures
Figure 1. Angioedema Treatment Picture
Figure 2. Global Angioedema Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Angioedema Treatment Market Share by Type: 2024 VS 2031
Figure 4. Antihistamines Features
Figure 5. Corticosteroids Features
Figure 6. Others Features
Figure 7. Global Angioedema Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Angioedema Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Research Organizations Case Studies
Figure 12. Angioedema Treatment Report Years Considered
Figure 13. Global Angioedema Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Angioedema Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Angioedema Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Angioedema Treatment Market Share by Players in 2024
Figure 17. Global Top Angioedema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angioedema Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Angioedema Treatment Revenue in 2024
Figure 19. North America Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Angioedema Treatment Market Share by Country (2020-2031)
Figure 21. United States Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Angioedema Treatment Market Share by Country (2020-2031)
Figure 25. Germany Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Angioedema Treatment Market Share by Region (2020-2031)
Figure 33. China Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Angioedema Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Angioedema Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Angioedema Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. AstraZeneca Revenue Growth Rate in Angioedema Treatment Business (2020-2025)
Figure 49. F.Hoffmann-La Roche AG Revenue Growth Rate in Angioedema Treatment Business (2020-2025)
Figure 50. Bausch Health Revenue Growth Rate in Angioedema Treatment Business (2020-2025)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Angioedema Treatment Business (2020-2025)
Figure 52. AstraZeneca Revenue Growth Rate in Angioedema Treatment Business (2020-2025)
Figure 53. Sanofi SA Revenue Growth Rate in Angioedema Treatment Business (2020-2025)
Figure 54. Merck＆Co Revenue Growth Rate in Angioedema Treatment Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
